Abstract
Yao Q-S, Varma RS, Liu SXL, Chiou GCY. Prevention of lens protein-, endotoxin-, and interleukin-1-induced uveitis with chalcone derivatives. Inflammopharmacology. 1994;2:401-409.
In order to develop potent non-steroidal anti-inflammatory agents, a new class of agents unrelated to those known to inhibit the arachidonate cascade were investigated. Most of the chalcone derivatives studied, including flavanone hydrazone (RCV/FLV 574), 2’-(o-hydroxyphenol)-5-phenylpyrazoline (RCV-556Pz), 2’-acetoxychalcone-iV-monoacetylhydrazone (RVC-576) and 7V-(o-hydroxybenzoyl) morpholine (RVC-570), inhibited lens protein-induced ocular inflammation effectively at a dose level of 1% (50 μ1 as did prednisolone. Flavanone hydrazone (RCV/FLV 574) was the only compound among all these derivatives which inhibited endotoxin- and interleukin-1 (IL-1)-induced uveitis at 3 mg/kg ip tid this being approximately 7-fold more potent than prednisolone at 20 mg/kg ip tid. It is concluded that a non-steroidal non-arachidonate-mediated potent anti-inflammatory agent based on this compound could be developed with IL-1 blocking activity. However, flavanone hydrazone was rather toxic at effective doses tested. Modification of the chemical structure to reduce its side-effects would, therefore seem essential.
Similar content being viewed by others
References
Masuda K. Anti-inflammatory agents: Non-steroidal anti-inflammatory drugs. In: Sears ML, ed. Pharmacology of the eye. New York: Springer-Verlag; 1984:539–51.
Braquet P. Handbook of PAF and PAF antagonists. Boca Raton, FL: CRC Press; 1991.
Melli M, Parente L. Cytokines and lipocortins in inflammation and differentiation. New York: Wiley-Liss; 1991.
Dawson MM. Lymphokines and interleukins. Boca Raton, FL: CRC Press; 1991.
Dinarello CA. Modalities for reducing interleukin-1 activity in disease. Trends Pharmacol Sci. 1993; 14:155–9.
Granowitz Ev, Porat R, Mier Jw, Pribble Jp, Stiles Dm, Bloedow Dc, Catalona MA, Wolff SM, Dinarello CA. Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine. 1992;4:353–60.
Chiou GCY, Chang MS. Ocular inflammation induced by lens protein and its prevention with new agents. In: Bazan NG, ed. New trends in lipid mediators research. Lipid mediators in eye inflammation. Basel: Karger; 1990; 94–109.
Chiou GCY, Yao QS, Varma RS. Inhibition of ocular inflammation by chalcone derivatives and prednisolone. J Ocular Pharmacol. 1992;8:213–23.
Manna F, Chimenti F, Bolosco A, Cenicola ML, Amico MD, Parillo C, Rossi F, Marmo E. Anti-inflammatory, analgesic and antipyretic N-acetyl-2-pyrazolines and dihydrothienocoumarines. Eur J Med Chem. 1992;27:633–9.
Kallay F, Janzso G, Koczar I. The reaction of flavanone with hydrazine. Tetrahedron. 1965;21:19–24.
Kallay F, Janzso G, Koczar I. Thermal rearrangement of 2′-hydroxychalcone hydrazone and flavanone hydrazone derivatives. Tetrahedron. 1965;21:3037–41.
Miyano K, Chiou GCY. Pharmacological prevention of ocular inflammation induced by lens proteins. Ophth Res. 1984; 16:256–63.
Chiou GCY, Chang MS. Ocular inflammation induced by lens protein and its prevention with new agents (Review). In: Bazan NG, ed. New trends in lipid mediators research. Lipid mediators in eye inflammation. Basel: Karger; 1990: 94–10.
Chiou GCY, Yao QS, Li BHP. Inhibition of lens protein-, endotoxin-, and interleukin-1-induced ocular inflammation with osthole and some other non-steroidal anti-inflammatory agents. Inflammopharmacology. 1993;2:5–13.
Chiou LY, Chiou GCY. Ocular anti-inflammatory action of a lipoxygenase inhibitor in the rabbit. J Ocular Pharmacol. 1985;l:383–90.
Dziezyc J, Millichamp NJ, Rodhe BH, Baker JS, Chiou GCY. Effects of lipoxygenase inhibitors in a model of lens-induced uveitis in the dog. Am J Vet Res. 1989;50:1877–82.
Chang MS, Chiou GY. Prevention of lens protein induced ocular inflammation with cyclooxygenase and lipoxygenase inhibitors. J Ocular Pharmacol. 1989;5:353–60.
Chuang CY, Xiao JG, Chiou GCY. Ocular anti-inflammatory actions of matrine. J Ocular Pharmacol. 1987;3:129–34.
Chiou GCY, Shen ZF, Zhao F. Treatment and prevention of ocular inflammation with Chinese herbs. Int J Oriental Med. 1991;16:144–50.
Chang MS, Ziao JG, Chiou GCY. Prevention of ocular inflammation by matrine, prednisolone, and cyclooxygenase and lipoxygenase inhibitors. Acta Pharmacol Sinica. 1991;12:121–5.
Yao QS, Chiou GCY. Inhibition of crystallin-induced inflammation in rabbit eyes with five phytogenic compounds. Acta Pharmacol Sinica. 1993;14:13–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yao, Q.S., Varma, R.S., Liu, S.X.L. et al. Prevention of Lens Protein–, Endotoxin– , and Interleukin– 1– induced uveitis with chalcone derivatives. Inflammopharmacology 2, 401–409 (1994). https://doi.org/10.1007/BF02678606
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02678606